Rotavirus genotype dynamics in Pakistan: G9 and G12 emerging as dominant strains in vaccinated children (2019)

Asma Sadiq1, Jadoon Khan2, Abdul Basit1

  • 1Department of Microbiology, University of Jhang, Jhang, Pakistan.

Acta Tropica
|June 23, 2024
PubMed

Insights

Rotavirus A (RVA) molecular characterization in vaccinated Pakistani children revealed G9P[8] as the most common genotype. This highlights the need for ongoing surveillance to track RVA strains and improve vaccine effectiveness against childhood gastroenteritis.

Area of Science:

  • Virology
  • Pediatrics
  • Public Health

Background:

  • Rotavirus A (RVA) is a major cause of severe gastroenteritis in children globally.
  • Vaccination is a key strategy to mitigate RVA-related morbidity and mortality.
  • Understanding circulating RVA genotypes is crucial for vaccine efficacy and public health strategies.

Purpose of the Study:

  • To perform molecular characterization of Rotavirus A genotypes in vaccinated children in Pakistan.
  • To determine the prevalence and distribution of RVA genotypes in children under five years of age.
  • To analyze the association of RVA gastroenteritis with age groups and dehydration.

Main Methods:

  • Collection of 510 stool samples from children aged 0-5 years with acute gastroenteritis.
  • Detection of RVA antigen using Enzyme-Linked Immunosorbent Assay (ELISA).
  • G/P genotyping of RVA-positive samples using Multiplex semi-nested reverse transcriptase PCR.

Main Results:

  • Rotavirus A was detected in 130 samples (25.4% prevalence).
  • The most prevalent genotype was G9P[8] (20%), followed by G12P[6] (17%) and G3P[8] (14%).
  • RVA gastroenteritis showed a significant association with younger age groups (0-6 months) and dehydration.

Conclusions:

  • Continuous surveillance and genomic analysis of RVA genotypes are essential in vaccinated populations.
  • The study provides insights into evolving RVA genotype circulation in Pakistan.
  • Findings underscore the need for improved vaccine coverage and effectiveness to reduce RVA disease burden.